Walleye Trading’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,100
| Closed | -$358K | – | 5635 |
|
|
2023
Q4 | $358K | Buy |
6,100
+4,500
| +281% | +$253K | ﹤0.01% | 3357 |
|
|
2023
Q3 | $69.7K | Sell |
1,600
-2,200
| -58% | -$78.5K | ﹤0.01% | 4115 |
|
|
2023
Q2 | $137K | Sell |
3,800
-800
| -17% | -$33K | ﹤0.01% | 3618 |
|
|
2023
Q1 | $171K | Buy |
+4,600
| New | +$207K | ﹤0.01% | 3609 |
|
|
2022
Q4 | – | Sell |
-19,300
| Closed | -$1.35M | – | 5550 |
|
|
2022
Q3 | $1.35M | Buy |
19,300
+17,300
| +865% | +$1.28M | ﹤0.01% | 2016 |
|
|
2022
Q2 | $134K | Buy |
2,000
+700
| +54% | +$44.5K | ﹤0.01% | 3980 |
|
|
2022
Q1 | $107K | Sell |
1,300
-1,500
| -54% | -$153K | ﹤0.01% | 4206 |
|
|
2021
Q4 | $411K | Buy |
2,800
+700
| +33% | +$109K | ﹤0.01% | 3149 |
|
|
2021
Q3 | $372K | Buy |
+2,100
| New | +$338K | ﹤0.01% | 3228 |
|
|
2021
Q1 | – | Sell |
-200
| Closed | -$44K | – | 5446 |
|
|
2020
Q4 | $44K | Buy |
+200
| New | +$43.2K | ﹤0.01% | 4217 |
|
|
2020
Q1 | – | Sell |
-8,600
| Closed | -$1.11M | – | 4724 |
|
|
2019
Q4 | $1.11M | Buy |
8,600
+300
| +4% | +$28.9K | 0.01% | 1707 |
|
|
2019
Q3 | $647K | Sell |
8,300
-900
| -10% | -$84.5K | 0.01% | 1932 |
|
|
2019
Q2 | $948K | Buy |
9,200
+3,800
| +70% | +$296K | 0.01% | 1647 |
|
|
2019
Q1 | $396K | Sell |
5,400
-3,400
| -39% | -$231K | ﹤0.01% | 2456 |
|
|
2018
Q4 | $373K | Buy |
+8,800
| New | +$351K | ﹤0.01% | 2783 |
|
Other funds holding MRTX
Walleye Trading's MRTX Position: Q1 2024 in Review
Walleye Trading sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 2,425 shares — an estimated $142K sold.
Walleye Trading first reported a position in MRTX in Q3 2016 and held it in 7 quarters. The position peaked at $1.09M in Q4 2019. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- Walleye Trading reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Walleye Trading sold 2,425 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $142K.
- Walleye Trading first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2016 and held it in 7 quarters.
- Walleye Trading's Mirati Therapeutics, Inc. Common Stock position peaked at $1.09M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.